MacroGenics, Inc. (MGNX)
2.23
+0.09
(+4.21%)
USD |
NASDAQ |
Mar 06, 16:00
2.245
+0.02
(+0.67%)
After-Hours: 20:00
MacroGenics Free Cash Flow : -164.76M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Amicus Therapeutics, Inc. | 29.85M |
| Merck & Co., Inc. | 12.36B |
| CorMedix, Inc. | 172.79M |
| Xencor, Inc. | -138.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -30.19M |
| Cash from Investing (Quarterly) | -20.37M |
| Free Cash Flow Per Share (Quarterly) | -0.4837 |
| Free Cash Flow to Equity (Quarterly) | -30.37M |
| Free Cash Flow to Firm (Quarterly) | -27.27M |
| Free Cash Flow Yield | -117.3% |